智通财经APP讯,天大药业(00455)发布公告,由2025年6月27日起:独立非执行董事赵崇康不再担任公司的提名委员会成员;独立非执行董事冼彦芳获委任为提名委员会成员;及独立非执行董事林日辉已委任为首席独立非执行董事。首席独立非执行董事并非公司的行政职务,亦不担任集团任何管理职务。
更多港股重磅资讯,下载智通财经app
更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.